Cystic renal cell carcinoma (cystic RCC) is a subgroup of renal cell carcinoma in which the cystic component predominates. It accounts for approximately 5-7% of all kidney cancers. Most commonly associated with clear cell histology (ccRCC), although papillary, chromophobe, and other subtypes can also demonstrate cystic degeneration. Cystic RCC generally presents at a lower stage and grade compared to its solid counterpart and carries a better prognosis, with 5-year survival rates exceeding 90%. The Bosniak classification system is the fundamental guide for managing cystic renal lesions: Bosniak III lesions are malignant in 40-60%, while Bosniak IV lesions are malignant in 85-100%. On imaging, multilocular cystic architecture, enhancing septa and/or mural nodules, irregular wall thickening, and the presence of solid components raise suspicion for malignancy. MRI is superior to CT for detecting thin septal enhancement and mural nodules. Partial nephrectomy (nephron-sparing surgery) is the preferred treatment; active surveillance is also an option for small lesions.
Age Range
40-80
Peak Age
60
Gender
Male predominant
Prevalence
Uncommon
The formation mechanism of cystic RCC involves multiple pathways. The most common scenario is when a solid clear cell RCC undergoes intratumoral necrosis, hemorrhage, and cystic degeneration — in this case, the tumor is initially solid and develops central necrosis as it grows, creating cystic spaces. The second mechanism is when the tumor demonstrates a cystic growth pattern from the outset: multilocular cystic renal neoplasm (formerly multilocular cystic nephroma-like RCC) belongs to this group and is considered a neoplasm of low malignant potential. The third mechanism is de novo malignant transformation from the wall of a pre-existing simple or complex cyst — this is the rarest pathway. Cystic RCC frequency is increased in VHL (Von Hippel-Lindau) syndrome; VHL protein loss leads to HIF-alpha accumulation and VEGF overexpression, facilitating both solid and cystic RCC development. In clear cell histology, intracellular glycogen and lipid accumulation, along with protein and blood product accumulation in cystic spaces, determines the T1 and T2 signal characteristics on MRI. Enhancing solid components (septal thickening, mural nodules, wall irregularity) reflect the tumor's capacity for vascular neoangiogenesis and indicate malignancy.
A solid nodular component in the wall or septum of a cystic renal lesion demonstrating prominent enhancement in the arterial phase. This is the defining finding of Bosniak IV classification and indicates malignancy in 85-100% of cases. The mural nodule represents the most aggressive solid component of the tumor and shows strong correlation with invasive carcinoma at surgical pathology. Confirmed by >15 HU enhancement increase on CT, or positive enhancement on MRI subtraction images. This finding is considered the 'gold standard' for cystic RCC diagnosis and mandates surgical intervention.
Prominent enhancing mural nodule in the wall or septum of a cystic lesion (>15 HU increase). The nodule typically shows most prominent enhancement in the arterial phase; may exhibit a hypervascular pattern in clear cell histology. The size, shape, and enhancement intensity of the mural nodule show strong correlation with the presence of invasive cancer at surgical pathology. This is the defining finding of Bosniak IV classification and warrants surgical intervention.
Report Sentence
An enhancing mural nodule is identified in the wall/septum of the cystic renal lesion in the arterial phase (Bosniak IV); cystic renal cell carcinoma should be considered as the leading diagnosis and surgical intervention should be planned.
Enhancing thick (≥3 mm) and irregular septa in the nephrographic phase. Septal thickness may be non-uniform; focal nodular thickening areas may represent early stages of mural nodule development. Enhancement may show irregular distribution along the septa. The nephrographic phase is more reliable than the arterial phase for evaluating septal enhancement because the renal parenchyma enhances homogeneously, providing a reference. Compatible with Bosniak III (thick enhancing septa, no mural nodule) or Bosniak IV (mural nodule present).
Report Sentence
Enhancing thick (≥3 mm), irregular septa are identified in the cystic renal lesion in the nephrographic phase (Bosniak III-IV); cystic renal cell carcinoma should be prioritized in the differential diagnosis.
Multilocular cystic architecture on T2-weighted images; cystic compartments generally show high signal (fluid content) while heterogeneous signal areas may be present due to hemorrhage or proteinaceous content. Septa show low signal on T2, and their thickness is evaluated. Solid components (mural nodules) show intermediate-to-low signal on T2 and are distinguished from cystic fluid. Hemorrhagic cystic compartments may show signal loss on T2 (hemosiderin effect). The T2 sequence is the most informative sequence for evaluating the internal architecture of a cystic lesion (number of locules, septal thickness, presence of solid component).
Report Sentence
A multilocular cystic lesion is identified in the kidney on T2-weighted images, with cystic compartments showing high signal and septa showing low signal; heterogeneous signal in some compartments is compatible with hemorrhagic/proteinaceous content.
Signal of cystic compartments on T1-weighted images varies according to content. Simple serous fluid shows low signal on T1, while hemorrhagic or high-protein content produces high signal on T1 (paramagnetic effect of methemoglobin). Different T1 signal intensities in different compartments reflect hemorrhages occurring at different times or different protein concentrations. If T1 hyperintensity does not show signal loss on fat suppression sequences (not fat) and does not show enhancement on subtraction images, it is compatible with hemorrhagic content. This heterogeneous T1 signal pattern differs from the homogeneous low signal of a simple cyst and suggests a complex cystic lesion.
Report Sentence
Signal heterogeneity between compartments is identified in the cystic renal lesion on T1-weighted images, with T1 hyperintensity in some compartments compatible with hemorrhagic/proteinaceous content.
Subtraction images on contrast-enhanced MRI (post-contrast minus pre-contrast) are critically important for distinguishing true enhancement from intrinsic T1 hyperintensity (hemorrhage, protein). In cystic RCC, septa and mural nodules show distinct enhancement on subtraction images, while hemorrhagic compartments show no signal after subtraction. This technique, superior to CT, reveals malignancy indicators particularly in small and thinly enhancing septa. Enhancement on subtraction images is the most reliable MR criterion for Bosniak classification.
Report Sentence
True enhancement is confirmed in the septa and mural nodule of the cystic lesion on contrast-enhanced MRI subtraction images; hemorrhagic compartments show no enhancement — this pattern is compatible with cystic renal cell carcinoma.
Complex cystic appearance on US: multilocular cystic structure, internal echogenic septa, solid mural nodule in the cyst wall or septum. Cystic components may be anechoic (simple fluid) or hypoechoic (proteinaceous/hemorrhagic fluid). The mural nodule is generally seen as a hypoechoic-isoechoic solid lesion protruding from the cyst wall or septum. Thin septa (<1 mm) are difficult to see on US; septa 3 mm and above are reliably evaluated. US is valuable as a screening modality for initial detection but CT/MRI is required for enhancement evaluation.
Report Sentence
A complex multilocular cystic lesion is identified in the kidney on US with internal septa and a solid nodular component in the septum/wall; further characterization with CT or MRI and Bosniak classification is recommended.
Detection of vascularity in mural nodule or thickened septa on color Doppler US. Cystic compartments and simple septa are avascular. Detection of flow signal in a mural nodule or thickened septum indicates perfused solid tissue and raises suspicion for malignancy. A hypervascular pattern may be present in clear cell histology. The presence of Doppler signal is the US equivalent of enhancement findings on CT or MRI, but Doppler sensitivity is limited in small or deeply located lesions.
Report Sentence
Vascularity is detected in the solid component of the cystic renal lesion (mural nodule/thickened septum) on Doppler US; this suggests the presence of an enhancing solid component and further evaluation with CT/MRI is recommended.
Restricted diffusion in mural nodules and solid components on diffusion-weighted imaging (DWI) (high signal at high b-value + low ADC value). Cystic compartments generally show high ADC values (free water diffusion). The high cellularity of solid tumoral tissue restricts water diffusion by limiting intra- and extracellular space. Low signal of solid components on ADC map (ADC <1.5 x 10⁻³ mm²/s) supports tumoral tissue. DWI is a supplementary tool for characterizing solid components in addition to enhancement evaluation.
Report Sentence
Restricted diffusion is detected in the solid components (mural nodule) of the cystic renal lesion on DWI (high signal at high b-value, low signal on ADC map); this finding supports cellular tumoral tissue.
Criteria
Entirely cystic multilocular cystic lesion without expansile solid nodules. Septa separating cysts are lined by low-grade clear cell tumor cells but do not demonstrate expansile solid growth. Defined as a separate entity in the WHO 2022 classification. May be classified as Bosniak III or IIF.
Distinct Features
Excellent prognosis (no risk of metastasis or recurrence); nephron-sparing surgery is curative. On imaging, multilocular cystic structure with thin enhancing septa but NO mural nodule is observed. Cystic compartments contain clear or mildly hemorrhagic fluid. Can also occur in childhood (in the form of cystic nephroma). Staged as pT1a.
Criteria
Initially solid clear cell RCC that undergoes central necrosis, hemorrhage, and cystic degeneration as it grows. Solid enhancing tumor tissue is preserved in the peripheral wall or septa. Mural nodule and irregular thick wall/septa are present. Falls into Bosniak IV classification.
Distinct Features
Thick, irregular wall and septa with prominent enhancing mural nodule. Heterogeneous appearance on CT/MRI: solid components show hypervascular enhancement, cystic areas reflect necrosis/hemorrhage. Prognosis may be slightly better than solid ccRCC (more necrosis = less viable tumor volume) but depends on stage and grade. High signal in hemorrhagic compartments on T1 is typical.
Criteria
Single compartment (unilocular) cystic lesion; no or minimal septa. One or more enhancing mural nodules in the cyst wall. Cystic fluid is usually simple in character (may contain protein/hemorrhage). Less common; Bosniak IV.
Distinct Features
May create diagnostic difficulty due to resemblance to a simple cyst; detection of the mural nodule is key. When the nodule is small, it may be missed on CT; MRI subtraction is more sensitive. May be seen on US as a solid protrusion in the cyst wall. Prognosis is generally good; presents at low stage and grade.
Criteria
Cystic degeneration form of papillary RCC. Papillary RCC accounts for 10-15% of all RCCs; the cystic form is rare. Type 1 papillary RCC more frequently shows cystic degeneration. Enhancement is less prominent compared to clear cell type (hypovascular).
Distinct Features
Hypovascular enhancement pattern unlike clear cell type — solid components show mild homogeneous enhancement. High signal on T1 due to hemorrhage is frequent. Typically low signal on T2 (hemosiderin, papillary architecture). Does not show opposed-phase signal drop (no intracellular lipid). Prognosis is good in type 1, worse in type 2.
Distinguishing Feature
Bosniak III lesions contain thickened enhancing septa but no definite mural nodule. The Bosniak IV form of cystic RCC harbors a distinct mural nodule. 40-60% of Bosniak III lesions turn out to be malignant; therefore Bosniak III can also be cystic RCC. Septal thickness, irregularity, and the presence of focal nodular thickening are evaluated in differential diagnosis.
Distinguishing Feature
The Bosniak IV definition already encompasses cystic lesions containing enhancing mural nodules with an 85-100% malignancy rate. Cystic RCC is the most common histological diagnosis of Bosniak IV lesions. Other Bosniak IV lesions (cystic Wilms, cystic metastasis, cystic nephroma with malignancy) should be considered in differential diagnosis. CT/MRI findings are similar and surgical pathology provides the definitive diagnosis.
Distinguishing Feature
Solid clear cell RCC presents as a homogeneous or heterogeneous solid mass without undergoing cystic degeneration. Shows intense hypervascular enhancement in the arterial phase with washout in the nephrographic phase. Cystic RCC is characterized by a predominantly cystic structure (>50% cystic). Opposed-phase signal drop can be seen in both on MRI (intracellular lipid). The cystic form generally presents at a lower stage and grade with a better prognosis.
Distinguishing Feature
Multilocular cystic nephroma is an entirely cystic multilocular lesion without mural nodules or solid expansile components. Septa are thin and regular; enhancement is minimal or absent. Shows a bimodal age distribution: in male children (<4 years) and middle-aged women. Definitive differentiation from cystic RCC (especially MCRN-LMP) may be difficult by imaging; surgical pathology may be required. Herniation sign (protrusion of the lesion into the renal pelvis) is commonly seen in cystic nephroma.
Distinguishing Feature
Simple cyst (Bosniak I) has a thin smooth wall, homogeneous fluid density (0-20 HU), and DOES NOT contain septa/calcification/mural nodule/enhancement. Cystic RCC harbors enhancing septa, mural nodules, or irregular wall thickening. >15 HU enhancement increase on CT is the most reliable criterion distinguishing simple cyst from cystic RCC. Simple cyst shows homogeneous signal on all MRI sequences: low T1, high T2, no enhancement.
Urgency
urgentManagement
surgicalBiopsy
Not NeededFollow-up
specialist-referralIn the diagnosis of cystic RCC, the Bosniak classification determines management decisions. Bosniak IV lesions (enhancing mural nodule) are 85-100% malignant and surgical intervention (partial or radical nephrectomy) is mandatory — biopsy is not needed, surgery is both diagnostic and therapeutic. For Bosniak III lesions, surgery is recommended (40-60% malignancy) or active surveillance (imaging at 6-month intervals) may be applied. Cystic RCC has a better prognosis compared to its solid counterpart; the MCRN-LMP subtype has no risk of metastasis or recurrence. Post-surgical follow-up: every 6 months for the first 2 years, then annual CT/MRI surveillance. Partial nephrectomy (nephron-sparing) is preferred for T1a lesions (<4 cm). Multiple and bilateral cystic lesions may develop in VHL syndrome; genetic counseling and regular follow-up are recommended.
Cystic RCC requires surgical resection. Cystic-dominant subtypes generally have better prognosis than solid RCC. Multilocular cystic RCC has the best prognosis. Partial nephrectomy is preferred when feasible.